End-of-life care matters: Palliative cancer care results in better care and lower costs

Oncologist

Volumn 22, Issue 4, 2017, Pages 361-368

  Dalal, Shalini ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer costs; End of life; Palliative care; Value in EOL care

Indexed keywords

ARTICLE; BEREAVEMENT; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER STAGING; CAREGIVER SUPPORT; CLINICAL OUTCOME; CLINICAL TRIAL (TOPIC); COST OF ILLNESS; DYSPNEA; EMERGENCY WARD; FAMILY ATTITUDE; FAMILY STRESS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPICE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERPERSONAL COMMUNICATION; MEDICARE; MULTICENTER STUDY (TOPIC); PALLIATIVE THERAPY; PATIENT PREFERENCE; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHARED DECISION MAKING; TERMINAL CARE; TERMINALLY ILL PATIENT; ECONOMICS; PROCEDURES;

HUMANS; PALLIATIVE CARE; TERMINAL CARE;

EID: 85017438559     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2016-0277     Document Type: Article

References (112)

1. Ferrell B, Sun V, Hurria A et al. Interdisciplinary palliative care for patients with lung cancer. J Pain Symptom Manage 2015; 50: 758-767.
2. Grudzen CR, Richardson LD, Johnson PN et al. Emergency department-initiated palliative care in advanced cancer: A randomized clinical trial. JAMA Oncol 2016 [Epub ahead of print].
3. Greer JA, Tramontano AC, McMahon PM et al. Cost analysis of a randomized trial of early palliative care in patients with metastatic nonsmall-cell lung cancer. J Palliat Med 2016; 19: 842-848.
4. Zimmermann C, Swami N, Krzyzanowska M et al. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial. Lancet 2014; 383: 1721-1730.
5. Kavalieratos D, Corbelli J, Zhang D. Association between palliative care and patient and caregiver outcomes: A systematic review and meta-analysis. JAMA. 2016; 316: 2104-2114.
6. Bakitas MA, Tosteson TD, Li Z et al. Early versus delayed initiation of concurrent palliative oncology care: Patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33: 1438-1445.
7. Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-smallcell lung cancer. N Engl JMed 363: 733-42, 2010
8. Bakitas M, Lyons KD, Hegel MT et al. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: Baseline findings, methodological challenges, and solutions. Palliat Support Care 2009; 7: 75-86.
9. United States Committee on Ways and Means, United States Committee on Energy and Commerce, Committee on Education and Labor et al. Compilation of Patient Protection and Affordable Care Act: As amended through November 1, 2010 including Patient Protection and Affordable Care Act, healthrelated portions of the Health Care, and Education Reconciliation Act of 2010. Washington, D.C.: U.S. Government Printing Office, 2010.
10. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm: A new health system for the 21st century. Washington, D.C.: National Academy Press, 2001.
11. Porter ME. What is value in health care? N Engl JMed 2010; 363: 2477-2481.
12. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31: 58-69.
13. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG et al. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007; 18: 1437-1449.
14. Steinhauser KE, Clipp EC, McNeilly M et al. In search of a good death: Observations of patients, families, and providers. Ann Intern Med 2000; 132: 825-832.
15. Approaching death: Improving care at the end of life-A report of the Institute of Medicine. Health Serv Res 1998; 33: 1-3.
16. Morrison RS, Maroney-Galin C, Kralovec PD et al. The growth of palliative care programs in United States hospitals. J Palliat Med 2005; 8: 1127-1134.
17. National Hospice and Palliative Care Organization. NHPCO’s facts and figures on hospice care in America. Alexandria,VA: National Hospice and Palliative Care Organization, 2015.
18. Earle CC, Park ER, Lai B et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003; 21: 1133-1138.
19. Earle CC, Landrum MB, Souza JM et al. Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 2008; 26: 3860-3866.
20. Jacobson JO, Neuss MN, Hauser R. Measuring and improving value of care in oncology practices: ASCO programs from quality oncology practice initiative to the rapid learning system. Am Soc Clin Oncol Educ Book 2012: e70-e76.
21. Singer AE, Meeker D, Teno JM et al. Symptom trends in the last year of life from 1998 to 2010: A cohort study. Ann Intern Med 2015; 162: 175-183.
22. Teno JM, Freedman VA, Kasper JD et al. Is care for the dying improving in the United States? J Palliat Med 2015; 18: 662-666.
23. Committee on Approaching Death, Institute of Medicine. Dying in America: Improving quality and honoring individual preferences near the end of life. Mil Med 2015; 180: 365-367.
24. Committee on Improving the Quality of Cancer Care, Levit L, Balogh A, eds. Delivering high-quality cancer care: Charting a new course for a systemin Crisis. Washington, D.C.: National Academies Press, 2013.
25. Pritchard RS, Fisher ES, Teno JM et al. Influence of patient preferences and local health system characteristics on the place of death. SUPPORT investigators. Study to Understand Prognoses and Preferences for Risks and Outcomes of Treatment. J Am Geriatr Soc 1998; 46: 1242-1250.
26. Connors AF Jr., Dawson NV, Desbiens NA et al. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274: 1591-1598.
27. Barnato AE, Herndon MB, Anthony DL et al. Are regional variations in end-of-life care intensity explained by patient preferences?: A study of the US Medicare population. Med Care 2007; 45: 386-393.
28. Rose JH, O’Toole EE, Dawson NV et al. Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 2004; 22: 4907-4017.
29. Townsend J, Frank AO, Fermont D et al. Terminal cancer care and patients’ preference for place of death: A prospective study. BMJ 1990; 301: 415-417.
30. Gott M, Seymour J, Bellamy G et al. Older people’s views about home as a place of care at the end of life. Palliat Med 2004; 18: 460-467.
31. Barnato AE, Anthony DL, Skinner J et al. Racial and ethnic differences in preferences for end-of-life treatment. J Gen Intern Med 2009; 24: 695-701.
32. Barnato AE, McClellan MB, Kagay CR et al. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res 2004; 39: 363-375.
33. Teno JM, Clarridge BR, Casey V et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004; 291: 88-93.
34. Teno JM, Gozalo PL, Bynum JP et al. Change in end-of-life care for Medicare beneficiaries: Site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 2013; 309: 470-477.
35. Bruera E, Sweeney C, Calder K et al. Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 2001; 19: 2883-2885.
36. Degner LF, Kristjanson LJ, Bowman D et al. Information needs and decisional preferences in women with breast cancer. JAMA 1997; 277: 1485-1492.
37. Yennurajalingam S, Parsons HA, Duarte ER et al. Decisional control preferences of Hispanic patients with advanced cancer from the United States and Latin America. J Pain Symptom Manage 2013; 46: 376-385.
38. Noguera A, Yennurajalingam S, Torres-Vigil I et al. Decisional control preferences, disclosure of information preferences, and satisfaction among Hispanic patients with advanced cancer. J Pain Symptom Manage 2014; 47: 896-905.
39. Singh JA, Sloan JA, Atherton PJ et al. Preferred roles in treatment decision making among patients with cancer: A pooled analysis of studies using the Control Preferences Scale. Am J Manag Care 2010; 16: 688-696.
40. Wright AA, Zhang B, Ray A et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673.
41. Wright AA, Keating NL, Ayanian JZ et al. Family perspectives on aggressive cancer care near the end of life. JAMA 2016; 315: 284-292.
42. Dionne-Odom JN, Azuero A, Lyons KD et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: Outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33: 1446-1452.
43. Dionne-Odom JN, Azuero A, Lyons KD et al. Family caregiver depressive symptom and grief outcomes from the ENABLE III randomized controlled trial. J Pain Symptom Manage 2016; 52: 378-385.
44. Cohen RA, Kirzinger WK. Financial burden of medical care: A family perspective. NCHS Data Brief 2014: 1-8.
45. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 2011; 29: 2821-2826.
46. Davidoff AJ, Erten M, Shaffer T et al. Out-ofpocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer 2013; 119: 1257-1265.
47. Goldman DP, Joyce GF, Lawless G et al. Benefit design and specialty drug use. Health Aff (Millwood) 2006; 25: 1319-1331.
48. Narang AK, Nicholas LH. Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer. JAMA Oncol 2016 [Epub ahead of print].
49. Delgado-Guay M, Ferrer J, Rieber AG et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. The Oncologist 2015; 20: 1092-1098.
50. Neumann PJ, Palmer JA, Nadler E et al. Cancer therapy costs influence treatment: A national survey of oncologists. Health Aff (Millwood) 2010; 29: 196-202.
51. Meghani SH, Hinds PS. Policy brief: The Institute of Medicine report Dying in America: Improving quality and honoring individual preferences near the end of life. Nurs Outlook 2015; 63: 51-59.
52. El-Jawahri A, LeBlanc T,VanDusen H et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: A randomized clinical trial. JAMA 2016; 316: 2094-2103.
53. Temel JS, El-Jawahri A, Greer JA et al. Randomized trial of early integrated palliative and oncology care. 2016 ASCO Annual Meeting. J Clin Oncol 2016; 34:(suppl; abstr 10003).
54. Higginson IJ, Finlay I, Goodwin DM et al. Do hospital-based palliative teams improve care for patients or families at the end of life? J Pain Symptom Manage 2002; 23: 96-106.
55. Bakitas M, Lyons KD, Hegel MT et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA 2009; 302: 741-749.
56. Balboni TA, Vanderwerker LC, Block SD et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol 2007; 25: 555-560.
57. Pantilat SZ, O’Riordan DL, Dibble SL et al. Hospital- based palliative medicine consultation: A randomized controlled trial. Arch Intern Med 2010; 170: 2038-2040.
58. Braiteh F, El Osta B, Palmer JL et al. Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 2007; 10: 948-955.
59. Gade G, Venohr I, Conner D et al. Impact of an inpatient palliative care team: A randomized control trial. J Palliat Med 2008; 11: 180-190.
60. Hui D, Shamieh O, Paiva CE et al. Minimal clinically important difference in the physical, emotional, and total symptom distress scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage 2016; 51: 262-269.
61. Hui D, Shamieh O, Paiva CE et al. Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer 2015; 121: 3027-3035.
62. Delgado-Guay MO, Parsons HA, Li Z et al. Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer 2009; 115: 437-445.
63. O’Mahony S,McHenry J, Blank AE et al. Preliminary report of the integration of a palliative care team into an intensive care unit. Palliat Med 2010; 24: 154-165.
64. Elsayem A, Swint K, Fisch MJ et al. Palliative care inpatient service in a comprehensive cancer center: Clinical and financial outcomes. J Clin Oncol 2004; 22: 2008-2014.
65. Casarett D, Johnson M, Smith D et al. The optimal delivery of palliative care: A national comparison of the outcomes of consultation teams vs inpatient units. Arch Intern Med 2011; 171: 649-655.
66. Lagman R, Rivera N,Walsh D et al. Acute inpatient palliative medicine in a cancer center: Clinical problems and medical interventions: A prospective study. AmJ Hosp Palliat Care 2007; 24: 20-28.
67. Kane RL, Wales J, Bernstein L et al. A randomised controlled trial of hospice care. Lancet 1984; 1: 890-894.
68. Teno JM, Shu JE, Casarett D et al. Timing of referral to hospice and quality of care: Length of stay and bereaved family members’ perceptions of the timing of hospice referral. J Pain Symptom Manage 2007; 34: 120-125.
69. Miller SC, Lima J, Gozalo PL et al. The growth of hospice care in U.S. nursing homes. J Am Geriatr Soc 2010; 58: 1481-1488.
70. Kris AE, Cherlin EJ, Prigerson H et al. Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study. Am J Geriatr Psychiatry 2006; 14: 264-269.
71. Connor SR, Pyenson B, Fitch K et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007; 33: 238-246.
72. Penrod JD, Deb P, Luhrs C et al. Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med 2006; 9: 855-860.
73. Penrod JD, Deb P, Dellenbaugh C et al. Hospital- based palliative care consultation: Effects on hospital cost. J Palliat Med 2010; 13: 973-979.
74. May P, Normand C, Morrison RS. Economic impact of hospital inpatient palliative care consultation: Review of current evidence and directions for future research. J Palliat Med 2014; 17: 1054-1063.
75. Morrison RS, Penrod JD, Cassel JB et al. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 2008; 168: 1783-1790.
76. Morrison RS, Dietrich J, Ladwig S et al. Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff (Millwood) 2011; 30: 454-463.
77. Ciemins EL, Blum L, Nunley M et al. The economic and clinical impact of an inpatient palliative care consultation service: A multifaceted approach. J Palliat Med 2007; 10: 1347-1355.
78. Bendaly EA, Groves J, Juliar B et al. Financial impact of palliative care consultation in a public hospital. J Palliat Med 2008; 11: 1304-1308.
79. Whitford K, Shah ND,Moriarty J et al. Impact of a palliative care consult service. Am J Hosp Palliat Care 2014; 31: 175-182.
80. Hanson LC, Usher B, Spragens L et al. Clinical and economic impact of palliative care consultation. J Pain Symptom Manage 2008; 35: 340-346.
81. May P, Garrido MM, Cassel JB et al. Palliative care teams’ cost-saving effect is larger for cancer patients with higher numbers of comorbidities. Health Aff (Millwood) 2016; 35: 44-53.
82. Smith TJ, Coyne P, Cassel B et al. A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med 2003; 6: 699-705.
83. Campbell ML, Guzman JA. Impact of a proactive approach to improve end-of-life care in a medical ICU. Chest 2003; 123: 266-271.
84. Campbell ML, Guzman JA. A proactive approach to improve end-of-life care in a medical intensive care unit for patientswith terminal dementia. Crit Care Med 2004; 32: 1839-1843.
85. Norton SA, Hogan LA, Holloway RG et al. Proactive palliative care in the medical intensive care unit: Effects on length of stay for selected high-risk patients. Crit Care Med 2007; 35: 1530-1535.
86. Bruera E, Neumann CM, Gagnon B et al. The impact of a regional palliative care program on the cost of palliative care delivery. J Palliat Med 2000; 3: 181-186.
87. May P, Garrido MM, Cassel JB et al. Prospective cohort study of hospital palliative care teams for inpatients with advanced cancer: Earlier consultation is associated with larger cost-saving effect. J Clin Oncol 2015; 33: 2745-2752.
88. Zhang B,Wright AA, Huskamp HA et al. Health care costs in the last week of life: Associations with end-of-life conversations. Arch Intern Med 2009; 169: 480-488.
89. Taylor DH Jr, Ostermann J, Van Houtven CH et al. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? Soc Sci Med 2007; 65: 1466-1478.
90. Mor V, Kidder D. Cost savings in hospice: Final results of the National Hospice Study. Health Serv Res 1985; 20: 407-422.
91. Brumley R, Enguidanos S, Jamison P et al. Increased satisfaction with care and lower costs: Results of a randomized trial of in-home palliative care. J Am Geriatr Soc 2007; 55: 993-1000.
92. Dev R, Del Fabbro E, Miles M et al. Growth of an academic palliative medicine program: Patient encounters and clinical burden. J Pain Symptom Manage 2013; 45: 261-271.
93. Hui D, Elsayem A, De la Cruz M et al. Availability and integration of palliative care at US cancer centers. JAMA 2010; 303: 1054-1061.
94. Dumanovsky T, Augustin R, Rogers M, et al. The growth of palliative care in US hospitals: A status report. J Palliat Med. 2016; 19: 8-15.
95. Hui D, Kim SH, Kwon JH et al. Access to palliative care among patients treated at a comprehensive cancer center. The Oncologist 2012; 17: 1574-1580.
96. Cheng WW, Willey J, Palmer JL et al. Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med 2005; 8: 1025-1032.
97. Osta BE, Palmer JL, Paraskevopoulos T et al. Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med 2008; 11: 51-57.
98. Good PD, Cavenagh J, Ravenscroft PJ. Survival after enrollment in an Australian palliative care program. J Pain Symptom Manage 2004; 27: 310-315.
99. Morita T, Akechi T, Ikenaga M et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol 2005; 23: 2637-2644.
100. Reville B, Miller MN, Toner RW et al. End-oflife care for hospitalized patients with lung cancer: Utilization of a palliative care service. J Palliat Med 2010; 13: 1261-1266.
101. Dalal S, Palla S, Hui D et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. The Oncologist 2011; 16: 105-111.
102. Davis MP, Bruera E, Morganstern D. Early integration of palliative and supportive care in the cancer continuum: Challenges and opportunities. Am Soc Clin Oncol Educ Book 2013: 144-150.
103. Dalal S, Bruera S, Hui D et al. Use of palliative care services in a tertiary cancer center. The Oncologist 2016; 21: 110-118.
104. Hui D, Bansal S, Strasser F et al. Indicators of integration of oncology and palliative care programs: An international consensus. Ann Oncol 2015; 26: 1953-1959.
105. Buss MK, Lessen DS, Sullivan AM et al. Hematology/ oncology fellows’ training in palliative care: Results of a national survey. Cancer 2011; 117: 4304-4311.
106. Arthur J, Yennurajalingam S, Williams J et al. Development of a question prompt sheet for cancer patients receiving outpatient palliative care. J Palliat Med 2016; 19: 883-887.
107. Delgado-Guay MO, Rodriguez-Nunez A, De la Cruz V et al. Advanced cancer patients’ reported wishes at the end of life: A randomized controlled trial. Support Care Cancer 2016; 24: 4273-4281.
108. Temel JS, Greer JA, Admane S et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-smallcell lung cancer: Results of a randomized study of early palliative care. J Clin Oncol 2011; 29: 2319-2326.
109. Dyar S, Lesperance M, Shannon R et al. A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: Results of a randomized pilot study. J Palliat Med 2012; 15: 890-895.
110. Prince-Paul M, Burant CJ, Saltzman JN et al. The effects of integrating an advanced practice palliative care nurse in a community oncology center: A pilot study. J Support Oncol 2010; 8: 21-27.
111. Dy SM, Aslakson R, Wilson RF et al. Closing the quality gap: Revisiting the state of the science (vol. 8: Improving health care and palliative care for advanced and serious illness). Evid Rep Technol Assess (Full Rep) 2012: 1-249.
112. Breffni Hannon, Nadia Swami, Ashley Pope et al. Early Palliative Care and Its Role in Oncology: A Qualitative Study. The Oncologist 2016; 21: 1387-1395.